Quick Takeaways
- 22NW Fund, LP filed SCHEDULE 13D/A for Lifecore Biomedical, Inc. Common Stock, par value $0.001 per share (LFCR).
- Disclosed ownership: 7.5%.
- Date of event: 27 May 2025.
Quoteable Key Fact
"22NW Fund, LP disclosed 7.5% ownership in Lifecore Biomedical, Inc. Common Stock, par value $0.001 per share (LFCR) on 27 May 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| 22NW Fund, LP | 7.5% | 2,975,398 | 2,975,398 | 0 | /s/ Aron R. English | Manager | 0001640809 |
| 22NW, LP | 7.5% | 2,975,398 | 2,975,398 | 0 | /s/ Aron R. English | President and Sole Shareholder | 0001694297 |
| 22NW Fund GP, LLC | 7.5% | 2,975,398 | 2,975,398 | 0 | /s/ Aron R. English | Manager | 0001770575 |
| 22NW GP, Inc. | 7.5% | 2,975,398 | 2,975,398 | 0 | /s/ Aron R. English | President and Sole Shareholder | 0001783663 |
| Aron R. English | 7.5% | 2,975,398 | 2,975,398 | 0 | /s/ Aron R. English | Individually and as attorney-in-fact for Nathaniel Calloway | 0001770436 |
| Bryson O. Hirai-Hadley | 0% | 583 | 583 | 0 | /s/ Bryson O. Hirai-Hadley | Bryson O. Hirai-Hadley | 0001888106 |
| Nathaniel Calloway | 0% | 0 | 0 | 0 | /s/ Aron R. English | As attorney-in-fact for Nathaniel Calloway | 0001952771 |